Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Reborn Coffee Inc., a specialty coffee retailer traded on NASDAQ as REBN, appointed Thomas Tran as COO and CTO to support the company's operational discipline, technology integration, and global licensing expansion. With over 25 years of technology and operational experience, Mr. Tran is expected to bolster the company’s efficiency and scalability,…
Vor Bio, a clinical-stage biotechnology company focused on autoimmune diseases, will provide a corporate update at the 2026 Jefferies Global Healthcare Conference. The presentation will highlight progress on telitacicept, their novel dual-target fusion protein currently in Phase 3 clinical development.
Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotech company developing targeted cancer therapies, announced CEO Brian Sullivan will present and meet investors at the Jefferies Global Healthcare and Goldman Sachs Annual Global Healthcare Conferences in June 2026. The company provided updates on ongoing Phase 3 and Phase 1b/2 clinical trials for i…
Eagle Nuclear Energy Corp. announced the completion of critical environmental and site-readiness initiatives at its Aurora Uranium Project, including the installation of a meteorological station, wetland delineation, and cultural and archaeological studies. These milestones advance the project through permitting and environmental reviews, underpinn…
HUHUTECH International Group's U.S. subsidiary secured a follow-on contract worth $936,000 from a leading U.S. semiconductor foundry to support expansion of production capacity at its Arizona facility. This contract builds on a previously awarded $3.0 million agreement and highlights HUHUTECH's growing presence in the U.S. semiconductor market unde…
NewGenIVF Group Limited has executed a Share Purchase Agreement to acquire an initial 2% equity stake in K25.ai, an AI-powered prediction market platform focused on the Asia-Pacific (APAC) region, with the right to increase ownership up to 10%. NewGenIVF also secured exclusive agency rights for K25.ai in selected APAC markets, creating a potential …
Osisko Development Corp. announced the forthcoming issuance of approximately 871,683 common shares to satisfy the fourth deferred payment installment of US$2.5 million linked to its 2022 acquisition of the Tintic Project in Utah. This payment is subject to approval by the TSX Venture Exchange and signifies ongoing financial obligations related to t…
Vivani Medical announced that CEO Adam Mendelsohn will present a company overview and meet with investors and partners at the Jefferies Global Healthcare Conference on June 4, 2026 in New York. The company focuses on developing miniature, ultra long-acting drug implants using its proprietary NanoPortal platform, targeting metabolic diseases such as…
GMEX Robotics Corporation, trading on NASDAQ under the ticker GMEX, presents a shareholder letter detailing its strategic transformation from fitness hardware to AI-driven robotics platforms. The company aims to develop a comprehensive 'Terminal and Brain' system merging robotics with AI, targeting commercialization across logistics, industrial aut…
Braiin Limited (NASDAQ: BRAI) announced the launch of its AI-native Living Infrastructure platform in New Zealand, aiming to unify fragmented tenant onboarding, utility connection, broadband enablement, and household commerce into one digital ecosystem. This expansion is part of Braiin's broader international PropTech growth strategy across the ANZ…
RenovoRx announced that the U.S. FDA granted Orphan Drug Designation for oxaliplatin delivered intra-arterially using its RenovoCath device for treating pancreatic cancer. This marks the company's third orphan designation related to pancreatic cancer and highlights its innovative targeted drug-delivery technology. The designation provides regulator…
Polaryx Therapeutics has successfully closed a $10 million private placement equity financing to fund the initiation of its Phase 2 SOTERIA basket trial evaluating its lead candidate, PLX-200, across multiple rare lysosomal storage disorders (LSDs). The financing extends the company's operating runway through Q2 2027 and supports advancement toward…
Blue Gold Limited, a Nasdaq-listed gold mining company, announced the appointment of James Samuelson as Chief Financial Officer effective June 1, 2026. Samuelson brings over 25 years of experience in corporate finance, capital markets, and mergers and acquisitions, poised to lead Blue Gold’s financial and strategic initiatives as it advances its mi…
XTEND, an AI-powered autonomous robotics company, was selected for the Phase II Qualifier of the U.S. Department of Defense's $1 billion Drone Dominance Program, aimed at procuring over 200,000 drones by 2027 for military deployment. The company plans to demonstrate its proprietary XOS operating system at the upcoming qualifier event. XTEND is set …
PRF Technologies Ltd. announced progress toward the commercial launch of DeepSolar Predict™, its AI-based platform designed to optimize revenue across renewable energy assets by integrating forecasting, storage intelligence, and real-time market decision support. The platform aims to help renewable asset operators improve forecasting accuracy, mana…
SEALSQ Corp announced that its QS7001 Post-Quantum Secure Element achieved the NIST SP 800-90B Entropy Source Validation, a key requirement for advancing to FIPS 140-3 and Common Criteria EAL5+ certifications. This milestone strengthens SEALSQ's position in providing quantum-resistant cryptographic hardware for regulated markets, including governme…
Lexicon Pharmaceuticals announces that its management team will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference, highlighting the company's ongoing drug development efforts across multiple therapeutic areas including neuropathic pain, hypertrophic cardiomyopathy, obesity, and other cardiometabolic conditions.
Stran & Company, a Nasdaq-listed marketing solutions provider, announced multiple new multi-year contract wins within the consumer retail vertical. The company secured a significant three-year uniform contract with a major U.S. grocery retailer expected to yield six-figure annual revenue, along with several additional promotional product orders fro…
Safe Harbor Financial, a leading fintech platform serving the regulated cannabis and hemp industries, has appointed Tyler Klimas and Sean Tonner to its Board of Directors. Klimas brings deep cannabis regulatory expertise, while Tonner adds extensive experience in strategic communications and public affairs. These additions aim to strengthen the com…
StoneX Group Inc. will host its fourth annual Natural Resources Summit in New York City on June 9-10, 2026. The event gathers market participants, executives, and experts to discuss key themes such as energy security, critical minerals, and supply chain resilience amid shifting geopolitical dynamics. The summit aims to foster dialogue and collabora…
PureCycle Technologies, Inc. announced that its Ironton, Ohio recycling facility has achieved ISO 9001:2015 certification, validating the company's quality management systems and operational maturity. This milestone provides independent assurance to customers about consistent product quality and supports PureCycle's portfolio of environmental and r…
Aclaris Therapeutics, a clinical-stage biopharmaceutical company focused on immuno-inflammatory diseases, announced its participation in the 2026 Jefferies Global Healthcare Conference where its CEO and leadership will present via a fireside chat and webcast. The event aims to communicate the company's progress and future plans to investors.
Microsoft is offering a rare Growth-at-a-Reasonable-Price setup near $415 after a pullback from last year's highs. Strong profitability (ROE 30%), $72.9B in free cash flow, low leverage, and a PE in the mid-20s support a long bias. Trade plan with entry at $412.84, stop at $398.00, and primary target $470.00 on a 180-trading-day horizon.
Fiserv, Inc. announced a strategic partnership with Cognition to deploy the AI software engineer Devin to accelerate the modernization of core banking technology and reduce the time it takes to deliver new capabilities to clients. This initiative supports faster release cycles and improved platform performance while maintaining stability and securi…
The closure of the Strait of Hormuz by Iran has not so far caused immediate, widespread shortages of jet fuel, but it has reshaped global trade routes. Buyers and refiners are sending cargoes across much longer distances to replace roughly 400,000 barrels per day in lost Middle Eastern exports, lifting European prices to record levels in April and …
